as a base to activate the OH group of 4-AP, allowing O-acylation and creating 4-APR as the sole product. 18, 19) Therefore this method enables the efficient preparation of two different types of retinoid derivative via the simple, selective coupling of retinoic acid to the NH 2 or OH group without protection. The structures of 4-HPR and 4-APR were elucidated by IR spectroscopy based on the carbonyl absorption frequencies of 1634 cm Ϫ1 for 4-HPR and 1716 cm Ϫ1 for 4-APR. Method D was used to introduce a butyryl group into derivatives 1A (4-HPR) and 1B (4-APR), producing derivatives 2A and 2B in yields of 91% and 93%, respectively.
To synthesize other retinamide and retinoate derivatives, we first synthesized target compounds 13, 14, and 15, as shown in Chart 2. To introduce selectively a butyryl group into the ortho-OH (R2) of 4-amino resorcinol 6, a series of reactions was performed. First, the amine of 6 was protected with Cbz-Cl (1.2 eq)/TEA (1.2 eq) to obtain the N-Cbz 7 in 89% yield. Acylation of 7 with butyryl chloride (1.5 eq)/NMM (1.5 eq) according to method D provided the monobutyrated compound 10 in 65% yield. Nitro compounds 11 and 12 were prepared from starting materials 8 and 9 by butyrylation of the OH or NH 2 group (R3) meta to the nitro group, in 61% and 72% yield, respectively. Compounds 10, 11, and 12 were catalytically hydrogenated with 10% Pd/C in MeOH, producing the corresponding compounds 13, 14, and 15 in high yields. Intermediates 13-15 were coupled with ATRA by selective N-or O-acylation according to methods A and B to give final compounds 3A-5A and 3B-5B, respectively, as shown in Table 1 . The structures of these compounds were verified by IR spectroscopy.
Consistent with the general notion that most synthetic retinoids are lipophilic, our retinoid derivatives ( Fig. 1) were insoluble in aqueous solvents and precipitated in vivo. Unfor-tunately, this was true for derivative 5B, which has significant biological activity (Table 2) . Derivative 5B has a terminal NH 2 group, which can form salts to increase its water solubility. Although the hydrochloride and hydrobromide salts were more hydrophilic, these compounds were very unstable under strongly acidic conditions. Therefore we prepared organic salts 5C-F by reacting the free base form of 5B with a stoichiometric amount of fumaric, maleic, tartaric, or pamoic acid in THF according to Method E, 20) as shown in Chart 3.
Effect of Retinoid Derivatives on RARs
To determine the activity and specificity of our retinoid derivatives on RAR subtypes, a series of conventional transcriptional assays was performed using a retinoid responsive reporter gene in the presence of each receptor. COS-1 cells were cotransfected with a receptor expression vector (RARa, b, and g in pSG5) and reporter gene [(RARE) 3 -tk-CAT], and treated with increasing concentrations of ATRA, 4-HPR, or other retinoids. CAT ELISA was used to measure the amount of CAT protein induced in response to the retinoid derivatives. For each retinoid and receptor, a dose-response curve was plotted. The concentration required for 50% activation (EC 50 value) was determined by interpolation from the curves ( Table 2) . ATRA, a physiological RAR ligand, strongly activated all three RARs with an EC 50 of 1.8-5.1ϫ10 Ϫ9 M. As previously reported, 4-HPR (1A) was selectively active for RARb and g. 21, 22) Retinamide derivatives 2A-5A, like 4-HPR, were all more active for RARb and g with a lower V max than ATRA, whereas retinoate derivatives 1B-5B, except for 3B, were as active as ATRA for all three RARs with a similar V max . At present, it is not clear why 3B is not as active as the other derivatives. The side functional group of 3B may interfere with the coactivator binding required for RAR activation, but this remains to be determined using a coactivator as in CBP and SRC-1. 23) Organic salts 5C and 5D were as active as their parental compound 5B for all RARs.
Cytotoxic Activity of Retinoid Derivatives The cytotoxic potential of the retinoid derivatives was investigated by determining their concentrations required for 50% growth inhibition (IC 50 value) for HCT116 colon cancer cells. Following treatment of the cells with increasing concentrations of retinoid derivatives (0, 0.5, 1, 2.5, 5, 10 mM) for 48 h, proliferation was assayed using MTT, and dose-response curves were plotted. The IC 50 value was determined by interpolation from the curves. As summarized in Table 2 , the IC 50 value of derivative 5B was 0.65 mM for HCT116 cells, which was 13fold better than that of 4-HPR (8.21 mM). The IC 50 values of the other derivatives was slightly better than (2B, 3A, B, 4A), similar to (1B, 2A), or much worse (4B, 5A) than that of 4-HPR. Of the retinamide derivatives, 3A and 4A were superior to 4-HPR, the parental retinamide. Retinoate derivatives 2B, 3B, and 5B were more cytotoxic than 4-HPR. Retinoate derivative 4B and retinamide derivative 5A were much less cytotoxic than 4-HPR. Interestingly, 4B was a strong ligand for all RARs, whereas 5A was nearly inactive for all RARs, suggesting that RAR activation is not correlated with cytotoxicity in HCT116 cells. Organic salts 5C and 5D were as cytotoxic as parental compound 5B in these cells. For a better clinical outcome, we searched for retinoid derivatives with a submicromolar IC 50 value and low side effects. Although the IC 50 value of 4-HPR is relatively high, its relatively few side effects made it useful in clinical trials. In this regard, our derivative 5B and its organic salt forms, the most effective of the derivatives tested, are promising cancer prodrugs, although their side effects and hygroscopicities remain to be determined in animal studies.
Using data not presented here, we found that the position of the butyryl group is critical for activity, especially in the case of 5B. A derivative with the butyryl group in the meta 
The dose-response curves were plotted using data obtained from transcription assays with individual RAR subtypes in the presence of increasing concentrations of test retinoid. EC 50 values, the concentrations required for 50% activation, were determined by interpolation of the curves. b) The dose-response curves were plotted by MTT assay as described in Experimental. IC 50 values, the concentrations required for 50% growth inhibition, were determined by interpolation of the curves. Each experiment was performed in triplicate and repeated a minimum of three times. c) pϽ0.05 for all IC 50 values. position of the amine group inhibited HCT116 cell growth 50 times more potently than did a derivative with the butyryl in the ortho position. When the butyryl groups of 3A and 5B were removed, the cytotoxic potential was completely abrogated. Furthermore, the number of carbons in the side functional group was also important in both 3A and 5B. A derivative with four carbons at that position, i.e., a butyryl group, was the most potent under our assay conditions. 24) These overall results suggest that increased cytotoxicity is closely associated with side chain length. Based on the structurefunction relationship, we propose that a cellular target protein(s) responds to the four-carbon fatty acid chain by direct association.
Conclusion
This paper describes a new synthetic method for retinoid derivatives that involves selectively controlling N-acylation (carboxamide) and O-acylation (carboxyl ester). Our method led to the facile synthesis of various retinoid derivatives in one pot directly from retinoic acid and aminophenol derivatives without protection. In terms of RAR activation, retinamide derivatives 2A-5A functioned like 4-HPR, i.e., they were specific for RAR b and g, whereas, like ATRA, retinoate derivatives 1B-5B were active for all three RARs without specificity. In cytotoxicity assays using HCT116 cells, we found that retinamide derivatives 3A and 4A and retinoate derivatives 2B, 3B, and 5B were superior to 4-HPR, the parental retinamide. Data derived from derivatives 4B and 5A indicated that RAR activation is not correlated with cytotoxicity. Organic salts 5C and 5D were similar to parent compound 5B in terms of RAR activation and cytotoxicity in HCT116 cells. Although the data were not shown, the increased cytotoxicity of retinoid derivatives appears to be closely associated with the side chain length of the functional group. From these overall results, we conclude that our derivative 5B and its organic salt forms, the most effective of the derivatives tested, are promising cancer prodrugs.
Experimental
ATRA was purchased from Sigma Chemical Co. (Sigma-Aldrich Korea, Seoul). The dry DMF was stored over 4-Å sieves and degassed before use by bubbling argon through it for at least 1 h. Dry CH 2 Cl 2 was obtained by distillation from CaH 2 . The other commercially available reagents and solvents were used without further purification. All reactions were conducted under an Ar atmosphere, except for those reactions utilizing water as a solvent. They were monitored by TLC (Merck Kieselgel 60, F 254 ). All the products prepared were purified by flash column chromatography on silica gel 60 (Merck, 230-400 mesh). 1 H-and 13 C-NMR spectra were recorded on a Brüker AC-200F and JEOL JNM EX-400 using CDCl 3 and DMSO-d 6 as a solvents. All chemical shifts (d) are quoted in ppm downfield from TMS and coupling constants (J) are given in Hz. Mass spectra were measured on an Agilent 1100 LC/MSD (API-ES) mass spectrometer, Micro MS-autospec/ OA Tof (HR-EI-MS). IR spectra were recorded on Perkin Elmer 16FPC FT-IR spectrophotometer and frequencies are given in reciprocal centimeters.
Method A. (2E,4E,6E,8E)-[3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-nona-2,4,6,8 -tetraenoylamino]-(4-hydroxy)phenylamide (1A, 4-HPR) To a solution of EDCI (0.13 g, 0.66 mmol) in dry CH 2 Cl 2 (5 ml) was added retinoic acid (0.10 g, 0.33 mmol) in dry CH 2 Cl 2 (5 ml). The solution was stirred at room temperature for 0.5 h. To this mixture were added 4amino phenol (0.053 g, 0.33 mmol) in dry DMF (2 ml) and DMAP (cat.), and the mixture was stirred for 4-5 h. The reaction was quenched with NH 4 Cl (aq.) and extracted with EtOAc (30 ml). The extracts were washed with H 2 O and brine, dried (Na 2 SO 4 ), and evaporated. The residue was purified by column chromatography (EtOAc/hexaneϭ1/4) to give 1A (0.062 g, 48%) as a yellow solid. mp 170-171°C. 1 {(2E,4E,6E,8E)-[3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8- 2E,4E,6E,8E )-3,7-Dimethyl-9-(2,6,6trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraenoate (1B, 4-APR) Yield: 49% as a yellow form. To a solution of DCC (0.14 g, 0.66 mmol) in dry CH 2 Cl 2 (5 ml) was added retinoic acid (0.10 g, 0.33 mmol) in dry CH 2 Cl 2 (5 ml). The solution was stirred at room temperature for 0.5 h. To this mixture were added 4-amino phenol (0.034 g, 0.33 mmol) in dry DMF (2 ml) and DMAP (cat.), and the mixture was stirred for 4-5 h. The reaction was quenched with NH 4 Cl (aq.) and extracted with EtOAc (30 ml). The extracts were washed with H 2 O and brine, dried (Na 2 SO 4 ), and evaporated. The residue was purified by column chromatography (EtOAc/hexaneϭ1/4) to give 1B (0.064 g, 49%) as a yellow form, mp 147-150°C. 1 
